Literature DB >> 32930650

Diagnostic Algorithm to Differentiate Benign Atypical Leiomyomas from Malignant Uterine Sarcomas with Diffusion-weighted MRI.

Cendos Abdel Wahab1, Anne-Sophie Jannot1, Pietro A Bonaffini1, Camille Bourillon1, Caroline Cornou1, Marie-Aude Lefrère-Belda1, Anne-Sophie Bats1, Isabelle Thomassin-Naggara1, Alexandre Bellucci1, Caroline Reinhold1, Laure S Fournier1.   

Abstract

Background Improving the differentiation of uterine sarcomas from atypical leiomyomas remains a clinical challenge and is needed to avoid inappropriate surgery. Purpose To develop a diagnostic algorithm including diffusion-weighted MRI criteria to differentiate malignant uterine sarcomas from benign atypical leiomyomas. Materials and Methods This case-control retrospective study identified women with an atypical uterine mass at MRI between January 2000 and April 2017, with surgery or MRI follow-up after 1 year or longer. A diagnostic algorithm including T2-weighted MRI and diffusion-weighted imaging (DWI) signal and apparent diffusion coefficient (ADC) values was developed to predict for sarcoma. The training set consisted of 51 sarcomas and 105 leiomyomas. Two external validation sets were used to evaluate interreader reproducibility (16 sarcomas; 26 leiomyomas) and impact of reader experience (29 sarcomas; 30 leiomyomas). Wilson confidence intervals (CIs) were calculated for sensitivity and specificity. Results Evaluated were 156 women (median age, 50 years; interquartile range, 44-63 years). Predictive MRI criteria for malignancy were enlarged lymph nodes or peritoneal implants, high DWI signal greater than that in endometrium, and ADC less than or equal to 0.905 × 10-3 mm2/sec. Conversely, a global or focal area of low T2 signal intensity and a low or an intermediate DWI signal less than that in endometrium or lymph nodes allowed readers to confidently diagnose as benign a uterine mass demonstrating one or more of these signs (P < .001) in 100% cases in all three data sets. The sensitivities and specificities of the algorithm for diagnosis of malignancy were 98% (50 of 51 masses; 95% CI: 90%, 100%) and 94% (99 of 105 masses; 95% CI: 88%, 98%) in the training set; 88% (14 of 16 masses; 95% CI: 64%, 97%) and 100% (26 of 26 masses; 95% CI: 87%, 100%) in the validation set; and 83% (24 of 29 masses; 95% CI: 65%, 92%) and 97% (29 of 30 masses; 95% CI: 83%, 99%) for the less experienced reader, respectively. Conclusion A diagnostic algorithm with predictive features including lymphadenopathy, high diffusion-weighted imaging signal with reference to endometrium, and low apparent diffusion coefficient enabled differentiation of malignant sarcomas from atypical leiomyomas, and it may assist inexperienced readers. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Méndez in this issue.

Entities:  

Year:  2020        PMID: 32930650     DOI: 10.1148/radiol.2020191658

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Uterine leiomyomas revisited with review of literature.

Authors:  Rishi Philip Mathew; Swati Francis; Vinayak Jayaram; Shameema Anvarsadath
Journal:  Abdom Radiol (NY)       Date:  2021-05-31

Review 2.  MR Imaging of uterine sarcomas: a comprehensive review with radiologic-pathologic correlation.

Authors:  Filipa Alves E Sousa; Joana Ferreira; Teresa Margarida Cunha
Journal:  Abdom Radiol (NY)       Date:  2021-09-01

Review 3.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

Review 4.  Preoperative Differentiation of Uterine Leiomyomas and Leiomyosarcomas: Current Possibilities and Future Directions.

Authors:  Klaudia Żak; Bartłomiej Zaremba; Alicja Rajtak; Jan Kotarski; Frédéric Amant; Marcin Bobiński
Journal:  Cancers (Basel)       Date:  2022-04-13       Impact factor: 6.575

Review 5.  Uterine fibroid-like tumors: spectrum of MR imaging findings and their differential diagnosis.

Authors:  Yenpo Lin; Ren-Chin Wu; Yen-Ling Huang; Kueian Chen; Shu-Chi Tseng; Chin-Jung Wang; Angel Chao; Chyong-Huey Lai; Gigin Lin
Journal:  Abdom Radiol (NY)       Date:  2022-03-26

Review 6.  Review of uterine fibroids: imaging of typical and atypical features, variants, and mimics with emphasis on workup and FIGO classification.

Authors:  Muhammad O Awiwi; Mohamed Badawy; Akram M Shaaban; Christine O Menias; Jeanne M Horowitz; Moataz Soliman; Corey T Jensen; Ayman H Gaballah; Juan J Ibarra-Rovira; Myra K Feldman; Mindy X Wang; Peter S Liu; Khaled M Elsayes
Journal:  Abdom Radiol (NY)       Date:  2022-05-13

7.  How to improve O-RADS MRI score for rating adnexal masses with cystic component?

Authors:  Victoria Assouline; Yohann Dabi; Aurélie Jalaguier-Coudray; Sanja Stojanovic; Ingrid Millet; Caroline Reinhold; Marc Bazot; Isabelle Thomassin-Naggara
Journal:  Eur Radiol       Date:  2022-03-24       Impact factor: 7.034

Review 8.  Diffusion-Weighted MRI in the Genitourinary System.

Authors:  Thomas De Perrot; Christine Sadjo Zoua; Carl G Glessgen; Diomidis Botsikas; Lena Berchtold; Rares Salomir; Sophie De Seigneux; Harriet C Thoeny; Jean-Paul Vallée
Journal:  J Clin Med       Date:  2022-03-30       Impact factor: 4.241

9.  Diagnostic interpretation of non-contrast qualitative MR imaging features for characterisation of uterine leiomyosarcoma.

Authors:  Hilal Sahin; Janette Smith; Jeries Paolo Zawaideh; Amreen Shakur; Luca Carmisciano; Iztok Caglic; Annemarie Bruining; Mercedes Jimenez-Linan; Sue Freeman; Helen Addley
Journal:  Br J Radiol       Date:  2021-06-16       Impact factor: 3.629

Review 10.  New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.

Authors:  Pamela Causa Andrieu; Sungmin Woo; Tae-Hyung Kim; Elizabeth Kertowidjojo; Anjelica Hodgson; Simon Sun
Journal:  Curr Opin Oncol       Date:  2021-09-01       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.